Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-24-022037

CEO, CFO, Director gave up 2,033 shares (to pay taxes)

  • CEO, CFO, Director acquired 7,068 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Finley John David CEO, CFO, Director 2024-05-28 Option exercise +1,622 10,059 D: show line 1 in the form
Finley John David CEO, CFO, Director 2024-05-28 Shares withheld for taxes −467 $4.76 $2,223 9,592 D: show line 2 in the form
Finley John David CEO, CFO, Director 2024-05-28 Option exercise +3,335 12,927 D: show line 3 in the form
Finley John David CEO, CFO, Director 2024-05-28 Shares withheld for taxes −959 $4.76 $4,565 11,968 D: show line 4 in the form
Finley John David CEO, CFO, Director 2024-05-28 Option exercise +2,111 14,079 D: show line 5 in the form
Finley John David CEO, CFO, Director 2024-05-28 Shares withheld for taxes −607 $4.76 $2,889 13,472 D: show line 6 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Finley John David CEO, CFO, Director 2024-05-28 Option exercise · Restricted Stock Units −1,622 0 D: show line 7 in the form
Finley John David CEO, CFO, Director 2024-05-28 Option exercise · Restricted Stock Units −3,335 0 D: show line 8 in the form
Finley John David CEO, CFO, Director 2024-05-28 Option exercise · Restricted Stock Units −2,111 0 D: show line 9 in the form
Loading xslF345X05/ownership.xml…